NGVTNYSEChemicals & Allied ProductsFiscal year ends December 31
Ingevity Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 30, 2026
$70.31+0.49 (+0.70%)
Close on Oct 19, 2026
- Market cap
- $2.48B
- P/E (TTM)
- 47.8
- Dividend yield
- –
Ingevity statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Chemicals & Allied Products companies for comparison
Valuation
| Measure | Ingevity | Industry median |
|---|---|---|
| Market Cap | $2.42B | $166.30M |
| Enterprise Value | $3.52B | $87.12M |
| PE Ratio | 47.83 | 19.67 |
| PS Ratio | 2.08 | 3.60 |
| PB Ratio | 51.54 | 2.03 |
| P/FCF Ratio | 15.60 | 17.44 |
| P/OCF Ratio | 11.46 | 13.32 |
Enterprise value
| Measure | Ingevity | Industry median |
|---|---|---|
| EV / Sales | 3.03 | 2.43 |
| EV / EBITDA | 25.45 | 14.69 |
| EV / FCF | 22.72 | 20.97 |
Income (trailing twelve months)
| Measure | Ingevity | Industry median |
|---|---|---|
| Revenue | $1.16B | $57.94M |
| Gross Profit | $477.10M | $90.47M |
| Pretax Income | $37.70M | -$14.72M |
| Net Income | $54.00M | -$22.46M |
| EBITDA | $138.30M | -$17.14M |
| EPS (Diluted) | $1.47 | -$0.83 |
Margins
| Measure | Ingevity | Industry median |
|---|---|---|
| Gross Margin | 41.1% | 52.3% |
| Pretax Margin | 3.25% | -13.0% |
| Profit Margin | 4.65% | -39.2% |
| EBITDA Margin | 11.9% | -31.3% |
| FCF Margin | 13.4% | -8.85% |
Returns
| Measure | Ingevity | Industry median |
|---|---|---|
| Return on Equity (ROE) | 64.4% | -53.2% |
| Return on Assets (ROA) | 3.16% | -41.0% |
Growth
| Measure | Ingevity | Industry median |
|---|---|---|
| Revenue Growth (YoY) | -1.38% | 6.01% |
| FCF Growth (YoY) | 3.06% | 2.34% |
| Revenue Growth (3Y CAGR) | -11.2% | 2.25% |
| Revenue Growth (5Y CAGR) | -0.81% | 6.42% |
Balance sheet
| Measure | Ingevity | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $97.40M | $62.64M |
| Total Debt | $1.20B | $120.13M |
| Net Cash (Debt) | -$1.10B | $15.77M |
| Net Cash Per Share | -$32.08 | $0.66 |
| Equity (Book Value) | $46.90M | $48.61M |
| Book Value Per Share | $1.36 | $1.36 |
| Tangible Book Value | -$94.70M | $23.01M |
| Working Capital | $206.20M | $75.09M |
Financial position
| Measure | Ingevity | Industry median |
|---|---|---|
| Current Ratio | 1.61 | 3.30 |
| Quick Ratio | 0.29 | 2.39 |
| Debt / Equity | 25.59 | 0.51 |
| Debt / EBITDA | 8.68 | 3.35 |
| Debt / FCF | 7.75 | 5.05 |
| Net Debt / EBITDA | 7.97 | 2.22 |
Cash flow (trailing twelve months)
| Measure | Ingevity | Industry median |
|---|---|---|
| Operating Cash Flow | $211.00M | -$12.39M |
| Capital Expenditures | -$56.10M | -$1.07M |
| Free Cash Flow | $154.90M | -$20.34M |
| FCF Per Share | $4.51 | -$0.42 |
Efficiency
| Measure | Ingevity | Industry median |
|---|---|---|
| Asset Turnover | 0.68 | 0.38 |
| Inventory Turnover | 3.65 | 2.67 |
| Revenue Per Employee | $773.53K | $398.96K |
| Profits Per Employee | $36.00K | -$705.27K |
| Employee Count | 1,500 | 74 |
Dividends and yields
| Measure | Ingevity | Industry median |
|---|---|---|
| Earnings Yield | 2.23% | -22.8% |
| FCF Yield | 6.41% | -9.02% |
| Buyback Yield | 5.92% | -0.73% |
| Shareholder Yield | 5.92% | 0.00% |
Shares
| Measure | Ingevity | Industry median |
|---|---|---|
| Shares Outstanding | 34,377,900 | 58,139,000 |
| Shares Change (YoY) | -1.35% | 11.1% |
| Shares Change (QoQ) | -1.16% | 0.54% |
| Float | 33,895,100 | 49,154,900 |
| Shares Held by Insiders | 1.40% | 11.6% |
| Shares Held by Institutions | 102.1% | 59.4% |
Taxes
| Measure | Ingevity | Industry median |
|---|---|---|
| Income Tax | $12.50M | $89.00K |
| Effective Tax Rate | 33.2% | 20.5% |
Scores
| Measure | Ingevity | Industry median |
|---|---|---|
| Graham Number | $6.72 | $17.04 |
| Graham Upside | -90.4% | -44.3% |
| Altman Z-Score | 2.34 | -0.27 |
| Piotroski F-Score | 6 | 4 |
Calculated by StockData from Ingevity's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.